Kala Bio, Inc. (KALA)

0.8203 -0.02 (-2.15%) USD  |  NASDAQ  |  Dec 09, 12:35
More

Kala Bio EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for KALA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Q32 Bio, Inc. Upgrade
PharmaCyte Biotech, Inc. Upgrade
Allogene Therapeutics, Inc. Upgrade
Akero Therapeutics, Inc. Upgrade
Belite Bio, Inc. --